Thursday 31 December 2009

Aspirin forte




Aspirin forte may be available in the countries listed below.


Ingredient matches for Aspirin forte



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Aspirin forte in the following countries:


  • Germany

Caffeine

Caffeine is reported as an ingredient of Aspirin forte in the following countries:


  • Germany

International Drug Name Search

Sunday 27 December 2009

Simecon




Simecon may be available in the countries listed below.


Ingredient matches for Simecon



Simeticone

Simeticone is reported as an ingredient of Simecon in the following countries:


  • Argentina

  • Thailand

International Drug Name Search

Saturday 26 December 2009

Perospirone Hydrochloride Hydrate




Perospirone Hydrochloride Hydrate may be available in the countries listed below.


Ingredient matches for Perospirone Hydrochloride Hydrate



Perospirone

Perospirone Hydrochloride Hydrate (JAN) is also known as Perospirone (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Coartem




In the US, Coartem (artemether/lumefantrine systemic) is a member of the drug class antimalarial combinations and is used to treat Malaria.

US matches:

  • Coartem

Ingredient matches for Coartem



Artemether

Artemether is reported as an ingredient of Coartem in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • Gabon

  • Guinea

  • Indonesia

  • Madagascar

  • Mali

  • Mauritania

  • Niger

  • Peru

  • Senegal

  • South Africa

  • Togo

  • United States

  • Zaire

Lumefantrine

Lumefantrine is reported as an ingredient of Coartem in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • Gabon

  • Guinea

  • Indonesia

  • Madagascar

  • Mali

  • Mauritania

  • Niger

  • Peru

  • Senegal

  • South Africa

  • Togo

  • United States

  • Zaire

International Drug Name Search

Monday 21 December 2009

Sulpirid real




Sulpirid real may be available in the countries listed below.


Ingredient matches for Sulpirid real



Sulpiride

Sulpiride is reported as an ingredient of Sulpirid real in the following countries:


  • Germany

International Drug Name Search

Friday 18 December 2009

Q.T. Ban Tech




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Q.T. Ban Tech



Pyrantel

Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Q.T. Ban Tech in the following countries:


  • United States

International Drug Name Search

Wednesday 9 December 2009

Derma Soothe


Generic Name: topical emollients (TOP i kal ee MOL i ents)

Brand Names: Aloe Vesta Cream, AlphaSoft, AmeriPhor, Aqua Glycolic, Aqua Lube, Aquaphor, Aveeno, Baby Lotion, Baby Oil, Bag Balm, Baza-Pro, Beta Care, Blistex Lip Balm, Carmex, CarraKlenz, CeraVe, CeraVe AM, Cetaphil Lotion, Chap Stick, Citraderm, CoolBottoms, Corn Huskers Lotion, Curel Moisture Lotion, Derma Soothe, Dr Scholl's Essentials Cracked Skin Repair, Eucerin, Herpecin-L, K-Y Jelly, Keri Lotion, Lamisilk Heel Balm, Lubri-Soft, Lubriderm, Mederma, Moisturel, Natural Ice, NeutrapHor, NeutrapHorus Rex, Neutrogena Cleansing, Neutrogena Lotion, Nivea, Nutraderm, Pacquin, Phisoderm, Pretty Feet & Hands, Proshield Skincare Kit, Remedy 4-in-1 Cleansing Lotion, Replens, Secura, Sensi-Care, Soft Sense, St. Ives, Theraplex Lotion, Vaseline Intensive Care


What are Derma Soothe (topical emollients)?

Emollients are substances that moisten and soften your skin.


Topical (for the skin) emollients are used to treat or prevent dry skin. Topical emollients are sometimes contained in products that also treat acne, chapped lips, diaper rash, cold sores, or other minor skin irritation.


There are many brands and forms of topical emollients available and not all are listed on this leaflet.


Topical emollients may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Derma Soothe (topical emollients)?


You should not use a topical emollient if you are allergic to it. Topical emollients will not treat or prevent a skin infection.

Ask a doctor or pharmacist before using this medication if you have deep wounds or open sores, swelling, warmth, redness, oozing, bleeding, large areas of skin irritation, or any type of allergy.


What should I discuss with my healthcare provider before using Derma Soothe (topical emollients)?


You should not use a topical emollient if you are allergic to it. Topical emollients will not treat or prevent a skin infection.

Ask a doctor or pharmacist if it is safe for you to use this medicine if you have:



  • deep wounds or open sores;




  • swelling, warmth, redness, oozing, or bleeding;




  • large areas of skin irritation;




  • any type of allergy; or



  • if you are pregnant or breast-feeding.

How should I use Derma Soothe (topical emollients)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Clean the skin where you will apply the topical emollient. It may help to apply this product when your skin is wet or damp. Follow directions on the product label.


Shake the product container if recommended on the label.

Apply a small amount of topical emollient to the affected area and rub in gently.


If you are using a stick, pad, or soap form of topical emollient, follow directions for use on the product label.


Do not use this product over large area of skin. Do not apply a topical emollient to a deep puncture wound or severe burn without medical advice.

If your skin appears white or gray and feels soggy, you may be applying too much topical emollient or using it too often.


Some forms of topical emollient may be flammable and should not be used near high heat or open flame, or applied while you are smoking.

Store as directed away from moisture, heat, and light. Keep the bottle, tube, or other container tightly closed when not in use.


What happens if I miss a dose?


Since this product is used as needed, it does not have a daily dosing schedule. Seek medical advice if your condition does not improve after using a topical emollient.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Derma Soothe (topical emollients)?


Avoid getting topical emollients in your eyes, nose, or mouth. If this does happen, rinse with water. Avoid exposure to sunlight or tanning beds. Some topical emollients can make your skin more sensitive to sunlight or UV rays.

Derma Soothe (topical emollients) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using the topical emollient and call your doctor if you have severe burning, stinging, redness, or irritation where the product was applied.

Less serious side effects are more likely, and you may have none at all.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Derma Soothe (topical emollients)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied products. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Derma Soothe resources


  • Derma Soothe Use in Pregnancy & Breastfeeding
  • Derma Soothe Support Group
  • 0 Reviews for Derma Soothe - Add your own review/rating


  • Biafine Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Campath Monograph (AHFS DI)

  • Campral Monograph (AHFS DI)

  • Camptosar Monograph (AHFS DI)

  • Diabinese Monograph (AHFS DI)

  • Kinerase Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Neosalus Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Promiseb Cream MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Derma Soothe with other medications


  • Dry Skin


Where can I get more information?


  • Your pharmacist can provide more information about topical emollients.


Friday 4 December 2009

Dexazone




Dexazone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dexazone



Dexamethasone

Dexamethasone is reported as an ingredient of Dexazone in the following countries:


  • France

International Drug Name Search

Tuesday 1 December 2009

Norflocin-Mepha




Norflocin-Mepha may be available in the countries listed below.


Ingredient matches for Norflocin-Mepha



Norfloxacin

Norfloxacin is reported as an ingredient of Norflocin-Mepha in the following countries:


  • Switzerland

International Drug Name Search

Monday 30 November 2009

Primsol


Primsol is a brand name of trimethoprim, approved by the FDA in the following formulation(s):


PRIMSOL (trimethoprim hydrochloride - solution; oral)



  • Manufacturer: FSC

    Approval date: January 24, 2000

    Strength(s): EQ 50MG BASE/5ML [RLD]

Has a generic version of Primsol been approved?


No. There is currently no therapeutically equivalent version of Primsol available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Primsol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
    Patent 5,763,449
    Issued: June 9, 1998
    Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
    Assignee(s): Ascent Pediatrics, Inc.
    A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste.
    Patent expiration dates:

    • August 7, 2016




  • Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
    Patent 5,962,461
    Issued: October 5, 1999
    Inventor(s): Anaebonam; Aloysius O. & Clemente; Emmett & Fawzy; Abdel A.
    Assignee(s): Ascent Pediatrics, Inc.
    A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste. The bitter tasting drugs claimed herein are vitamin and mineral preparations, trimethoprim, and guaifenesin.
    Patent expiration dates:

    • August 7, 2016



See also...

  • Primsol Solution Consumer Information (Wolters Kluwer)
  • Primsol Consumer Information (Cerner Multum)
  • Primsol Advanced Consumer Information (Micromedex)
  • Trimethoprim Consumer Information (Wolters Kluwer)
  • Trimethoprim Solution Consumer Information (Wolters Kluwer)
  • Trimethoprim Consumer Information (Cerner Multum)
  • Trimethoprim Advanced Consumer Information (Micromedex)
  • Trimethoprim AHFS DI Monographs (ASHP)

Friday 27 November 2009

Pendistrep




Pendistrep may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pendistrep



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Pendistrep in the following countries:


  • South Africa

Dihydrostreptomycin

Dihydrostreptomycin sulfate (a derivative of Dihydrostreptomycin) is reported as an ingredient of Pendistrep in the following countries:


  • South Africa

International Drug Name Search

Saturday 21 November 2009

Difnan




Difnan may be available in the countries listed below.


Ingredient matches for Difnan



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Difnan in the following countries:


  • Portugal

International Drug Name Search

Tuesday 17 November 2009

Beloc




Beloc may be available in the countries listed below.


Ingredient matches for Beloc



Metoprolol

Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Beloc in the following countries:


  • Austria

  • Colombia

  • Germany

  • Switzerland

  • Turkey

International Drug Name Search

Sunday 15 November 2009

Neurocetam




Neurocetam may be available in the countries listed below.


Ingredient matches for Neurocetam



Piracetam

Piracetam is reported as an ingredient of Neurocetam in the following countries:


  • Myanmar

International Drug Name Search

Thursday 12 November 2009

Spiramycine EG




Spiramycine EG may be available in the countries listed below.


Ingredient matches for Spiramycine EG



Spiramycin

Spiramycin is reported as an ingredient of Spiramycine EG in the following countries:


  • France

International Drug Name Search

Prepacol




Prepacol may be available in the countries listed below.


Ingredient matches for Prepacol



Bisacodyl

Bisacodyl is reported as an ingredient of Prepacol in the following countries:


  • Austria

  • Belgium

  • Germany

  • Luxembourg

International Drug Name Search

Tuesday 10 November 2009

Pizotifen Malate




Pizotifen Malate may be available in the countries listed below.


Ingredient matches for Pizotifen Malate



Pizotifen

Pizotifen Malate (BANM) is also known as Pizotifen (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Carbon-vegetal




Carbon-vegetal may be available in the countries listed below.


Ingredient matches for Carbon-vegetal



Charcoal

Charcoal, Activated is reported as an ingredient of Carbon-vegetal in the following countries:


  • Peru

International Drug Name Search

Wednesday 28 October 2009

Pylomid




Pylomid may be available in the countries listed below.


Ingredient matches for Pylomid



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Pylomid in the following countries:


  • Bosnia & Herzegowina

International Drug Name Search

Thursday 22 October 2009

Granuloma Inguinale Medications


Definition of Granuloma Inguinale: In the United States granuloma inguinale is a rarely encountered sexually-transmitted disease that results in surface destruction and granuloma formation in the skin and subcutaneous tissue.

Drugs associated with Granuloma Inguinale

The following drugs and medications are in some way related to, or used in the treatment of Granuloma Inguinale. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Tuesday 20 October 2009

Paracétamol Qualimed




Paracétamol Qualimed may be available in the countries listed below.


Ingredient matches for Paracétamol Qualimed



Paracetamol

Paracetamol is reported as an ingredient of Paracétamol Qualimed in the following countries:


  • France

International Drug Name Search

Monday 19 October 2009

Toprec




Toprec may be available in the countries listed below.


Ingredient matches for Toprec



Ketoprofen

Ketoprofen is reported as an ingredient of Toprec in the following countries:


  • France

International Drug Name Search

Sunday 18 October 2009

Acetylpheneturide




Acetylpheneturide may be available in the countries listed below.


Ingredient matches for Acetylpheneturide



Pheneturide

Acetylpheneturide (JAN) is also known as Pheneturide (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Poulcox




Poulcox may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Poulcox



Monensin

Monensin sodium salt (a derivative of Monensin) is reported as an ingredient of Poulcox in the following countries:


  • South Africa

International Drug Name Search

Wednesday 14 October 2009

Bronquisedan Elixir




Bronquisedan Elixir may be available in the countries listed below.


Ingredient matches for Bronquisedan Elixir



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bronquisedan Elixir in the following countries:


  • Argentina

International Drug Name Search

Monday 5 October 2009

Adventan




Adventan may be available in the countries listed below.


Ingredient matches for Adventan



Methylprednisolone

Methylprednisolone aceponate (a derivative of Methylprednisolone) is reported as an ingredient of Adventan in the following countries:


  • Spain

International Drug Name Search

Sunday 4 October 2009

Penegra




Penegra may be available in the countries listed below.


Ingredient matches for Penegra



Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Penegra in the following countries:


  • Ethiopia

  • India

  • Myanmar

International Drug Name Search

Friday 2 October 2009

Cochic




Cochic may be available in the countries listed below.


Ingredient matches for Cochic



Colchicine

Colchicine is reported as an ingredient of Cochic in the following countries:


  • Myanmar

International Drug Name Search

Famotidina Normon




Famotidina Normon may be available in the countries listed below.


Ingredient matches for Famotidina Normon



Famotidine

Famotidine is reported as an ingredient of Famotidina Normon in the following countries:


  • Spain

International Drug Name Search

Wednesday 30 September 2009

Pirazinid




Pirazinid may be available in the countries listed below.


Ingredient matches for Pirazinid



Pyrazinamide

Pyrazinamide is reported as an ingredient of Pirazinid in the following countries:


  • Bosnia & Herzegowina

  • Turkey

International Drug Name Search

Thursday 24 September 2009

Spersallerg




Spersallerg may be available in the countries listed below.


Ingredient matches for Spersallerg



Antazoline

Antazoline is reported as an ingredient of Spersallerg in the following countries:


  • Slovenia

Antazoline hydrochloride (a derivative of Antazoline) is reported as an ingredient of Spersallerg in the following countries:


  • Bulgaria

  • Germany

  • Norway

  • Oman

  • Poland

  • Slovakia

  • South Africa

  • Switzerland

Tetryzoline

Tetryzoline is reported as an ingredient of Spersallerg in the following countries:


  • Slovenia

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Spersallerg in the following countries:


  • Bulgaria

  • Germany

  • Norway

  • Oman

  • Poland

  • Slovakia

  • South Africa

  • Switzerland

International Drug Name Search

Monday 21 September 2009

Sitaxentan




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02KX03

CAS registry number (Chemical Abstracts Service)

0184036-34-8

Chemical Formula

C18-H15-Cl-N2-O6-S2

Molecular Weight

454

Therapeutic Category

Endothelin antagonist

Chemical Names

N-(4-Chlor-3-methylisoxazol-5-yl)-2-[(4,5-methylendioxy-2-methylphenyl)acetyl]thiophen-3-sulfonamid (IUPAC)

N-(4-Chlor-3-methylisoxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-sulfonamid

N-(4-Chloro-3-methyl-5-isoxazolyl)-2-[[4,5-(methylenedioxy)-o-tolyl]acetyl]-3-thiophenesulfonamide (WHO)

3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-[[6-methyl-1,3-benzodioxol-5-yl]acetyl]-

Foreign Names

  • Sitaxentanum (Latin)
  • Sitaxentan (German)
  • Sitaxentan (French)
  • Sitaxentan (Spanish)

Generic Names

  • IPI 1040 (IS)
  • Sitaxsentan (IS)
  • LGLS (IS)
  • TBC-11241 (IS)
  • TBC-11251 (IS: TexasBiotechn)
  • TBC-2576 (IS)
  • TBC-3214 (IS)

Brand Names

  • Thelin
    Praxis Pharmaceutical, Spain; CSL, Australia; Encysive, Austria; Encysive, Germany; Encysive, France; Encysive, United Kingdom; Encysive, Ireland; Encysive, Luxembourg; Encysive, Netherlands; LCA, Belgium; EncysiveUK Limited, Denmark


  • THELIN
    Pfizer, Sweden

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 20 September 2009

Renitab




Renitab may be available in the countries listed below.


Ingredient matches for Renitab



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Renitab in the following countries:


  • Myanmar

International Drug Name Search

Saturday 19 September 2009

Loratadina Farmindustria




Loratadina Farmindustria may be available in the countries listed below.


Ingredient matches for Loratadina Farmindustria



Loratadine

Loratadine is reported as an ingredient of Loratadina Farmindustria in the following countries:


  • Peru

International Drug Name Search

Monday 14 September 2009

Decavac


Generic Name: diphtheria and tetanus vaccine (Intramuscular route)


dif-THEER-ee-a TOX-oyd, ad-SORBD, TET-n-us TOX-oyd


Commonly used brand name(s)

In the U.S.


  • Decavac

Available Dosage Forms:


  • Suspension

Therapeutic Class: Vaccine


Uses For Decavac


Diphtheria and tetanus vaccine is a combination vaccine that is given to protect against infections caused by diphtheria and tetanus (lockjaw). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age and older, teenagers, and adults.


Diphtheria is a serious illness that can cause breathing problems, heart problems, nerve damage, pneumonia, and possibly death. The risk for serious illness is greater in very young children and the elderly.


Tetanus (also known as lockjaw) is a very serious illness that causes severe muscle spasms that make the muscles very rigid or stiff. The muscle spasms can be strong enough to cause bone fractures in the spine. The disease can also cause breathing problems, swallowing problems, seizures, and possibly death.


This vaccine is to be administered only by or under the direct supervision of a doctor.


Before Using Decavac


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of Diphtheria and Tetanus Toxoids Vaccine for Pediatric Use in children 7 years of age and older. Safety and efficacy have not been established.


Appropriate studies have not been performed on the relationship of age to the effects of Decavac® vaccine in children younger than 7 years of age. Safety and efficacy have not been established.


Geriatric


Although appropriate studies on the relationship of age to the effects of Decavac® vaccine have not been performed in the geriatric population, no geriatric-specific problems have been documented to date.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergic reaction to a tetanus vaccine (eg, Arthus-type reaction) or

  • Guillain-Barré syndrome (nerve disease that causes paralysis) after a tetanus vaccine, history of—Your doctor will decide if you should receive this vaccine.

  • Immunodeficiency disorder (low blood counts for white cells or platelets) or

  • Weakened immune system—May not work as well in patients with these conditions.

Proper Use of Decavac


A nurse or other trained health professional will give you or your child this vaccine. This vaccine is given as a shot into one of your muscles, usually in the upper leg for infants or in the shoulder for older children, teenagers, and adults.


Depending on the age of the child, this vaccine is given as a series of 3 or 4 doses. Teenagers and adults will receive a total of 3 doses.


After the first set of shots, you or your child should get a booster shot every 10 years.


It is important that you or your child receive all of the doses of vaccine in this series. Try to keep all of your scheduled appointments. If you miss a dose, make another appointment as soon as possible.


Precautions While Using Decavac


It is very important that you or your child return to your doctor’s office at the right time for the next dose. Be sure to notify your doctor of any unwanted effects that occur after you receive the vaccine.


If you or your child develop a skin rash, hives, or any allergic reaction after receiving this vaccine, tell your doctor right away.


Tell your doctor right away if you or your child are allergic to latex rubber. The prefilled syringes or bottle of vaccine may contain natural rubber latex. This may cause an allergic reaction in patients who are sensitive to latex.


This vaccine will not treat an active infection. If you or your child have an infection due to diphtheria or tetanus, you will need medicine to treat the infection.


Decavac Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


Less common
  • Fever

  • general feeling of discomfort or illness

  • unusual tiredness or weakness

Incidence not known
  • Bloating or swelling of the face, arms, hands, lower legs, or feet

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • chills

  • convulsions

  • cough

  • difficulty with swallowing

  • dizziness

  • fainting

  • fast heartbeat

  • hives

  • itching

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • rapid weight gain

  • shortness of breath

  • skin rash

  • swelling or puffiness of the face

  • swollen, painful, or tender lymph glands in the neck, armpit, or groin

  • tightness in the chest

  • tingling of the hands or feet

  • unusual weight gain or loss

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Hard lumps, redness, tenderness, or warmth at the injection site

Less common
  • Headache

Incidence not known
  • Difficulty with moving

  • joint pain

  • lack or loss of strength

  • muscle aching or cramping

  • muscle stiffness

  • nausea

  • pain in the arms or legs

  • swollen joints

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Decavac side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Decavac resources


  • Decavac Side Effects (in more detail)
  • Decavac Use in Pregnancy & Breastfeeding
  • Decavac Drug Interactions
  • 0 Reviews for Decavac - Add your own review/rating


Compare Decavac with other medications


  • Diphtheria Prophylaxis
  • Tetanus Prophylaxis

Thursday 10 September 2009

Irufen




Irufen may be available in the countries listed below.


Ingredient matches for Irufen



Ibuprofen

Ibuprofen is reported as an ingredient of Irufen in the following countries:


  • Bangladesh

International Drug Name Search

Monday 7 September 2009

Triject




Triject may be available in the countries listed below.


Ingredient matches for Triject



Ceftriaxone

Ceftriaxone is reported as an ingredient of Triject in the following countries:


  • Bangladesh

International Drug Name Search

Thursday 3 September 2009

Sertra Basics




Sertra Basics may be available in the countries listed below.


Ingredient matches for Sertra Basics



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertra Basics in the following countries:


  • Germany

International Drug Name Search

Wednesday 26 August 2009

Amoxicilina Pensa




Amoxicilina Pensa may be available in the countries listed below.


Ingredient matches for Amoxicilina Pensa



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Pensa in the following countries:


  • Spain

International Drug Name Search

Pipetexina




Pipetexina may be available in the countries listed below.


Ingredient matches for Pipetexina



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Pipetexina in the following countries:


  • Argentina

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Pipetexina in the following countries:


  • Argentina

International Drug Name Search

Saturday 22 August 2009

Preran




Preran may be available in the countries listed below.


Ingredient matches for Preran



Trandolapril

Trandolapril is reported as an ingredient of Preran in the following countries:


  • Japan

International Drug Name Search

Roxicure




Roxicure may be available in the countries listed below.


Ingredient matches for Roxicure



Roxithromycin

Roxithromycin is reported as an ingredient of Roxicure in the following countries:


  • Venezuela

International Drug Name Search

Captopril comp Basics




Captopril comp Basics may be available in the countries listed below.


Ingredient matches for Captopril comp Basics



Captopril

Captopril is reported as an ingredient of Captopril comp Basics in the following countries:


  • Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Captopril comp Basics in the following countries:


  • Germany

International Drug Name Search

Friday 21 August 2009

Cisplatine Teva




Cisplatine Teva may be available in the countries listed below.


Ingredient matches for Cisplatine Teva



Cisplatin

Cisplatin is reported as an ingredient of Cisplatine Teva in the following countries:


  • France

  • Luxembourg

  • Netherlands

International Drug Name Search

Acétate de Cyprotérone Teva




Acétate de Cyprotérone Teva may be available in the countries listed below.


Ingredient matches for Acétate de Cyprotérone Teva



Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Acétate de Cyprotérone Teva in the following countries:


  • France

International Drug Name Search

Thursday 13 August 2009

Barriere Cream





Dosage Form: cream
Barriere

Active ingredient


Dimethicone, 20%



Purpose


Skin Protectant



Use


▪ Temporarily protects and helps relieve chapped or cracked skin


▪ Helps protect from the drying effects of wind and cold weather


▪ Helps treat and prevent diaper rash


▪ Protects minor skin irritation due to diaper rash and helps seal out wetness



Warning


 ▪ For external use only



Do not use on


▪ Animal bites


▪ Deep or puncture wounds    


▪ Serious burns



When using this product


▪  do not get into eyes



Stop use and ask a doctor if


▪ Condition  worsens                                      


▪ Symptoms last more than 7 days or clear up and occur again within a few days



Keep out of reach of children



Directions


▪ For Skin Protection: Apply as needed      


▪ For Treatment or Prevention of Diaper Rash: Change wet and soiled diapers promptly, cleanse the diaper area, and allow to dry.  Apply cream liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.



Other information


▪ Store at 20-25°C (68-77°F)



Inactive ingredients


butylated hydroxytoluene, butylparaben, cetyl alcohol, edetate disodium, ethylparaben, fragrance, isobutylparaben, methylparaben, phenoxyethanol, propylene glycol, propylparaben, stearic acid, triethanolamine, water



Questions?


Call 1-866-337-4500



Distributed by


WellSpring Pharmaceutical Corporation

Sarasota, FL 34243 USA

(c) WellSpring 2010



Package Label. Principal Display Panel










BARRIERE 
dimethicone  cream










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)65197-426
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (DIMETHICONE)DIMETHICONE0.2 g  in 1 g






























Inactive Ingredients
Ingredient NameStrength
BUTYLATED HYDROXYTOLUENE 
BUTYLPARABEN 
CETYL ALCOHOL 
EDETATE SODIUM 
ETHYLPARABEN 
ISOBUTYLPARABEN 
METHYLPARABEN 
PHENOXYETHANOL 
PROPYLENE GLYCOL 
PROPYLPARABEN 
STEARIC ACID 
TROLAMINE 
WATER 


















Product Characteristics
ColorWHITE (white)Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
165197-426-01100 g In 1 TUBENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34708/02/2010


Labeler - WellSpring Pharmaceutical Corporation (110999054)









Establishment
NameAddressID/FEIOperations
WellSpring Pharmaceutical Canada Corp251086799ANALYSIS, LABEL, MANUFACTURE, PACK









Establishment
NameAddressID/FEIOperations
WellSpring Pharmaceutical Corporation110999054MANUFACTURE
Revised: 05/2010WellSpring Pharmaceutical Corporation




More Barriere Cream resources


  • Barriere Cream Use in Pregnancy & Breastfeeding
  • Barriere Cream Support Group
  • 8 Reviews for Barriere - Add your own review/rating


Compare Barriere Cream with other medications


  • Dry Skin

Wednesday 12 August 2009

Varizil




Varizil may be available in the countries listed below.


Ingredient matches for Varizil



Metronidazole

Metronidazole is reported as an ingredient of Varizil in the following countries:


  • Bangladesh

International Drug Name Search

Monday 10 August 2009

Fenergan




Fenergan may be available in the countries listed below.


Ingredient matches for Fenergan



Promethazine

Promethazine is reported as an ingredient of Fenergan in the following countries:


  • Argentina

  • Brazil

  • Portugal

International Drug Name Search

Sunday 9 August 2009

Difortan




Difortan may be available in the countries listed below.


Ingredient matches for Difortan



Naproxen

Naproxen is reported as an ingredient of Difortan in the following countries:


  • Poland

International Drug Name Search

Saturday 8 August 2009

Coroflox




Coroflox may be available in the countries listed below.


Ingredient matches for Coroflox



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Coroflox in the following countries:


  • Indonesia

International Drug Name Search

Monday 27 July 2009

Pentosan




Pentosan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pentosan



Pentosan Polysulfate

Pentosan Polysulfate sodium (a derivative of Pentosan Polysulfate) is reported as an ingredient of Pentosan in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Saturday 25 July 2009

Hydroxychloroquine Sulphate




Hydroxychloroquine Sulphate may be available in the countries listed below.


Ingredient matches for Hydroxychloroquine Sulphate



Hydroxychloroquine

Hydroxychloroquine Sulphate (BANM) is known as Hydroxychloroquine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 24 July 2009

Trioxyl




Trioxyl may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Trioxyl



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Trioxyl in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Sunday 19 July 2009

Pyohex




Pyohex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pyohex



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Pyohex in the following countries:


  • Australia

International Drug Name Search

Thursday 16 July 2009

Nystatin Holsten




Nystatin Holsten may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Nystatin Holsten



Nystatin

Nystatin is reported as an ingredient of Nystatin Holsten in the following countries:


  • Germany

Zinc Oxide

Zinc Oxide is reported as an ingredient of Nystatin Holsten in the following countries:


  • Germany

International Drug Name Search

Saturday 11 July 2009

Licef




Licef may be available in the countries listed below.


Ingredient matches for Licef



Cefadroxil

Cefadroxil is reported as an ingredient of Licef in the following countries:


  • Bangladesh

International Drug Name Search

Plenacor




Plenacor may be available in the countries listed below.


Ingredient matches for Plenacor



Atenolol

Atenolol is reported as an ingredient of Plenacor in the following countries:


  • Argentina

  • Colombia

  • Ecuador

International Drug Name Search

Friday 10 July 2009

Sertwin




Sertwin may be available in the countries listed below.


Ingredient matches for Sertwin



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertwin in the following countries:


  • Hungary

International Drug Name Search

Tuesday 7 July 2009

Ténectéplase




Ténectéplase may be available in the countries listed below.


Ingredient matches for Ténectéplase



Tenecteplase

Ténectéplase (DCF) is known as Tenecteplase in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 6 July 2009

Tylex




Tylex may be available in the countries listed below.


UK matches:

  • Tylex Capsules (SPC)
  • Tylex Effervescent (SPC)

Ingredient matches for Tylex



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Tylex in the following countries:


  • United Kingdom

Paracetamol

Paracetamol is reported as an ingredient of Tylex in the following countries:


  • Antigua & Barbuda

  • Aruba

  • Bahamas

  • Barbados

  • Cayman Islands

  • Costa Rica

  • Dominican Republic

  • Grenada

  • Guatemala

  • Guyana

  • Honduras

  • Ireland

  • Jamaica

  • Mexico

  • Netherlands Antilles

  • Nicaragua

  • Panama

  • Saint Lucia

  • Saint Vincent & The Grenadines

  • Suriname

  • Trinidad & Tobago

  • United Kingdom

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 5 July 2009

Hydrea




In some countries, this medicine may only be approved for veterinary use.


In the US, Hydrea (hydroxyurea systemic) is a member of the drug class antimetabolites and is used to treat Anemia - Sickle Cell, Chronic Myelogenous Leukemia, Polycythemia Vera and Solid Tumors.

US matches:

  • Hydrea

UK matches:

  • Hydrea Capsules 500mg
  • Hydrea 500 mg Hard Capsules (SPC)

Ingredient matches for Hydrea



Hydroxycarbamide

Hydroxycarbamide is reported as an ingredient of Hydrea in the following countries:


  • Algeria

  • Australia

  • Bahrain

  • Belgium

  • Brazil

  • Canada

  • Chile

  • Colombia

  • Denmark

  • Egypt

  • Estonia

  • Finland

  • Georgia

  • Hong Kong

  • Indonesia

  • Iran

  • Iraq

  • Ireland

  • Japan

  • Jordan

  • Kuwait

  • Latvia

  • Lebanon

  • Lithuania

  • Luxembourg

  • Netherlands

  • New Zealand

  • Oman

  • Portugal

  • Qatar

  • Romania

  • Saudi Arabia

  • Singapore

  • South Africa

  • Spain

  • Sweden

  • Syria

  • Taiwan

  • Thailand

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 26 June 2009

Macrozid




Macrozid may be available in the countries listed below.


Ingredient matches for Macrozid



Pyrazinamide

Pyrazinamide is reported as an ingredient of Macrozid in the following countries:


  • Ethiopia

International Drug Name Search

Monday 22 June 2009

Clidinium Bromide




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0003485-62-9

Chemical Formula

C22-H26-Br-N-O3

Molecular Weight

432

Therapeutic Categories

Antispasmodic agent

Parasympatholytic agent

Gastric acid secretion inhibitor

Chemical Name

1-Azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-, bromide

Foreign Names

  • Clidinii Bromidum (Latin)
  • Clidinium bromid (German)
  • Bromure de Clidinium (French)
  • Bromuro de clidinio (Spanish)

Generic Names

  • Clidinium Bromide (OS: USAN, BAN)
  • Clidinum (IS)
  • Ro 2-3773 (IS)
  • Clidinium Bromide (PH: USP 32)

Brand Names

  • Apo-Chlorax (Clidinium Bromide and Chlordiazepoxide)
    Apotex, Canada; Apotex, Singapore; Apotex, Vietnam


  • Braxidin (Clidinium Bromide and Chlordiazepoxide)
    Sanbe, Indonesia


  • Cliad (Clidinium Bromide and Chlordiazepoxide)
    Interbat, Indonesia


  • Distedon (Clidinium Bromide and Diazepam)
    Adelco, Greece


  • Kenspa (Clidinium Bromide and Chlordiazepoxide)
    Kenyaku, Thailand


  • Klidibrax (Clidinium Bromide and Chlordiazepoxide)
    Sandoz, Indonesia


  • Librax (Clidinium Bromide and Chlordiazepoxide)
    Combiphar, Indonesia; ICN, Bahrain; ICN Iberica SA, Greece; ICN Switzerland, Oman; IFET, Greece; Meda, France; Pharmaco, South Africa; PL, Thailand; Valeant, Canada; Valeant, Indonesia; Valeant, Italy; Valeant, Peru; Valeant Pharmaceuticals, Vietnam; Valeant Pharmaceuticals Switzerland GmbH, Switzerland


  • Librocol (Clidinium Bromide and Chlordiazepoxide)
    Lagap, Switzerland


  • Renagas (Clidinium Bromide and Chlordiazepoxide)
    Fahrenheit, Indonesia


  • Tumax (Clidinium Bromide and Chlordiazepoxide)
    Sriprasit, Thailand

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 18 June 2009

Allopurinol Stada




Allopurinol Stada may be available in the countries listed below.


Ingredient matches for Allopurinol Stada



Allopurinol

Allopurinol is reported as an ingredient of Allopurinol Stada in the following countries:


  • Germany

International Drug Name Search

Monday 15 June 2009

Omeprazol HG. Pharm




Omeprazol HG. Pharm may be available in the countries listed below.


Ingredient matches for Omeprazol HG. Pharm



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol HG. Pharm in the following countries:


  • Vietnam

International Drug Name Search

Wednesday 10 June 2009

Calciumfolinat Meda




Calciumfolinat Meda may be available in the countries listed below.


Ingredient matches for Calciumfolinat Meda



Calcium Folinate

Calcium Folinate is reported as an ingredient of Calciumfolinat Meda in the following countries:


  • Denmark

Calcium Folinate pentahydrate (a derivative of Calcium Folinate) is reported as an ingredient of Calciumfolinat Meda in the following countries:


  • Sweden

International Drug Name Search

Monday 8 June 2009

Clomipramine HCl PCH




Clomipramine HCl PCH may be available in the countries listed below.


Ingredient matches for Clomipramine HCl PCH



Clomipramine

Clomipramine hydrochloride (a derivative of Clomipramine) is reported as an ingredient of Clomipramine HCl PCH in the following countries:


  • Netherlands

International Drug Name Search

Thursday 28 May 2009

Gastroloc




Gastroloc may be available in the countries listed below.


Ingredient matches for Gastroloc



Ranitidine

Ranitidine is reported as an ingredient of Gastroloc in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday 27 May 2009

Conludag




Conludag may be available in the countries listed below.


Ingredient matches for Conludag



Norethisterone

Norethisterone is reported as an ingredient of Conludag in the following countries:


  • Norway

International Drug Name Search

Sunday 24 May 2009

Salmosan




Salmosan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Salmosan



Azamethiphos

Azamethiphos is reported as an ingredient of Salmosan in the following countries:


  • Norway

  • United Kingdom

International Drug Name Search

Thursday 14 May 2009

Nedipin




Nedipin may be available in the countries listed below.


Ingredient matches for Nedipin



Nifedipine

Nifedipine is reported as an ingredient of Nedipin in the following countries:


  • Taiwan

International Drug Name Search

Monday 11 May 2009

Dehydroemetine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01AX09

CAS registry number (Chemical Abstracts Service)

0004914-30-1

Chemical Formula

C29-H38-N2-O4

Molecular Weight

478

Therapeutic Category

Antiprotozoal agent, amebicide

Chemical Name

Emetan, 2,3-didehydro-6',7',10,11-tetramethoxy-

Foreign Names

  • Dehydroemetinum (Latin)
  • Dehydroemetin (German)
  • Déhydroémétine (French)
  • Dehidroemetina (Spanish)

Generic Names

  • Dehydroemetine (OS: BAN)
  • Déhydroémétine (OS: DCF)
  • BT 436 (IS)

Brand Name

  • Dehydroemetine
    Roche, Ethiopia

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 27 April 2009

Zeraplix




Zeraplix may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Zeraplix



Zeranol

Zeranol is reported as an ingredient of Zeraplix in the following countries:


  • South Africa

International Drug Name Search

Friday 24 April 2009

Adrenol




Adrenol may be available in the countries listed below.


Ingredient matches for Adrenol



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Adrenol in the following countries:


  • Argentina

Trimethoprim

Trimethoprim is reported as an ingredient of Adrenol in the following countries:


  • Argentina

International Drug Name Search

Tuesday 21 April 2009

Enagon




Enagon may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Enagon



Gonadorelin

Gonadorelin is reported as an ingredient of Enagon in the following countries:


  • Italy

International Drug Name Search

Monday 20 April 2009

Budesonid Arrow




Budesonid Arrow may be available in the countries listed below.


Ingredient matches for Budesonid Arrow



Budesonide

Budesonide is reported as an ingredient of Budesonid Arrow in the following countries:


  • Denmark

  • Sweden

International Drug Name Search

Thursday 16 April 2009

Drinkmix Colistine




Drinkmix Colistine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Drinkmix Colistine



Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Drinkmix Colistine in the following countries:


  • Netherlands

International Drug Name Search

Wednesday 15 April 2009

Siflam




Siflam may be available in the countries listed below.


Ingredient matches for Siflam



Ibuprofen

Ibuprofen is reported as an ingredient of Siflam in the following countries:


  • Bangladesh

International Drug Name Search

Saturday 11 April 2009

Biométhasone




Biométhasone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biométhasone



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Biométhasone in the following countries:


  • France

International Drug Name Search

Friday 10 April 2009

Pravastatina Dermogeneris




Pravastatina Dermogeneris may be available in the countries listed below.


Ingredient matches for Pravastatina Dermogeneris



Pravastatin

Pravastatin is reported as an ingredient of Pravastatina Dermogeneris in the following countries:


  • Spain

International Drug Name Search

Thursday 9 April 2009

Exelon


Exelon is a brand name of rivastigmine, approved by the FDA in the following formulation(s):


EXELON (rivastigmine - film, extended release; transdermal)



  • Manufacturer: NOVARTIS

    Approval date: July 6, 2007

    Strength(s): 4.6MG/24HR, 9.5MG/24HR [RLD]

EXELON (rivastigmine tartrate - capsule; oral)



  • Manufacturer: NOVARTIS

    Approval date: April 21, 2000

    Strength(s): EQ 1.5MG BASE [RLD][AB], EQ 3MG BASE [AB], EQ 4.5MG BASE [AB], EQ 6MG BASE [AB]

EXELON (rivastigmine tartrate - solution; oral)



  • Manufacturer: NOVARTIS

    Approval date: April 21, 2000

    Strength(s): EQ 2MG BASE/ML [RLD]

Has a generic version of Exelon been approved?


A generic version of Exelon has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Exelon and have been approved by the FDA:


rivastigmine tartrate capsule; oral



  • Manufacturer: DR REDDYS LABS INC

    Approval date: October 31, 2007

    Strength(s): EQ 1.5MG BASE [AB], EQ 3MG BASE [AB], EQ 4.5MG BASE [AB], EQ 6MG BASE [AB]


  • Manufacturer: SUN PHARM INDS

    Approval date: October 22, 2007

    Strength(s): EQ 1.5MG BASE [AB], EQ 3MG BASE [AB], EQ 4.5MG BASE [AB], EQ 6MG BASE [AB]


  • Manufacturer: WATSON LABS

    Approval date: January 8, 2008

    Strength(s): EQ 1.5MG BASE [AB], EQ 3MG BASE [AB], EQ 4.5MG BASE [AB], EQ 6MG BASE [AB]

Note: No generic formulation of the following products are available.


  • rivastigmine - film, extended release; transdermal

  • rivastigmine tartrate - solution; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Exelon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Phenyl carbamates
    Patent 4,948,807
    Issued: August 14, 1990
    Inventor(s): Rosin; Marta W. & Chorev; Michael & Tashma; Zeev
    Assignee(s): Proterra AG
    Phenyl carbamates of the general formula ##STR1## wherein R.sub.1 to R.sub.5 are as defined in the claims, are useful as pharmaceuticals.
    Patent expiration dates:

    • August 14, 2012
      ✓ 
      Patent use: TREATMENT OF ALZHEIMER'S DEMENTIA
      ✓ 
      Drug substance




  • Phenyl carbamate
    Patent 5,602,176
    Issued: February 11, 1997
    Inventor(s): Enz; Albert
    Assignee(s): Sandoz Ltd.
    The (S)-N-ethyl-3-[(1-dimethylamino)ethyl]-N-methyl-phenylncarbamate in free base or acid addition salt form is useful as pharmaceutical, particularly for systemic transdermal administration.
    Patent expiration dates:

    • February 11, 2014
      ✓ 
      Patent use: TREATMENT OF ALZHEIMER'S DEMENTIA
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • February 11, 2014
      ✓ 
      Patent use: TREATMENT OF ALZHEIMER'S DEMENTIA




  • TTS containing an antioxidant
    Patent 6,316,023
    Issued: November 13, 2001
    Inventor(s): Asmussen; Bodo & Horstmann; Michael & Kopke; Kai & Tiemessen; Henricus L. G. M. & Dinh; Steven Minh & Gargiulo; Paul M.
    Assignee(s): Novartis AG
    LTS Lohmann Therapie-Systeme GmbH
    Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an antioxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Patent expiration dates:

    • January 8, 2019
      ✓ 
      Drug product




  • TTS containing an antioxidant
    Patent 6,335,031
    Issued: January 1, 2002
    Inventor(s): Bodo; Asmussen & Michael; Horstmann & Kai; Köpke & Henricus L. G. M.; Tiemessen & Steven Minh; Dinh & Paul M.; Gargiulo
    Assignee(s): Novartis AG
    LTS Lohmann Therapie-Systeme GmbH Co. KG
    Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.
    Patent expiration dates:

    • January 8, 2019
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • July 6, 2010 - NEW DOSAGE FORM

See also...

  • Exelon Consumer Information (Drugs.com)
  • Exelon Consumer Information (Wolters Kluwer)
  • Exelon Patch Consumer Information (Wolters Kluwer)
  • Exelon Solution Consumer Information (Wolters Kluwer)
  • Exelon Consumer Information (Cerner Multum)
  • Exelon Advanced Consumer Information (Micromedex)
  • Exelon Transdermal Advanced Consumer Information (Micromedex)
  • Exelon AHFS DI Monographs (ASHP)
  • Rivastigmine Consumer Information (Wolters Kluwer)
  • Rivastigmine Patch Consumer Information (Wolters Kluwer)
  • Rivastigmine Solution Consumer Information (Wolters Kluwer)
  • Rivastigmine Consumer Information (Cerner Multum)
  • Rivastigmine transdermal Consumer Information (Cerner Multum)
  • Rivastigmine Advanced Consumer Information (Micromedex)
  • Rivastigmine Transdermal Advanced Consumer Information (Micromedex)
  • Rivastigmine AHFS DI Monographs (ASHP)